Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
294.79 USD | +0.43% |
|
+2.05% | +13.10% |
08:08am | Amgen Insider Sold Shares Worth $7,341,123, According to a Recent SEC Filing | MT |
02-10 | Piper Sandler Adjusts Amgen Price Target to $329 From $310, Maintains Overweight Rating | MT |
Revenues (N-1) | Net margin (N-1) | EBIT margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
---|---|---|---|---|---|---|---|
28.19B | 23.83% | 47.53% | 202.85% | 12.37% | 3.07x | ||
34.12B | 15.36% | 20.68% | 48.93% | 9.23% | 2.6x | ||
40.31B | 34.78% | 44.19% | 80.78% | 25.88% | 0.52x | ||
85.16B | 41.28% | 32.25% | 34.91% | 14.32% | 0.21x | ||
54.32B | 8.95% | 45.64% | 143.18% | 14.46% | 1.82x | ||
66.76B | 13.68% | 34.42% | 43.45% | 15.69% | 0.74x | ||
45.81B | 13.01% | 31.73% | 29.77% | 11.48% | 1.66x | ||
60.12B | 0.61% | 10.33% | 9.18% | 3.56% | 2.77x | ||
50.32B | 23.73% | 38.74% | 34.74% | 15.58% | 0.85x | ||
58.5B | 3.62% | 15.9% | 11.37% | 4.96% | 3.8x | ||
47.61B | 12.54% | 29.42% | 13.65% | 4.27% | 0.55x | ||
27.12B | 20.89% | 38.66% | 38.46% | 13.49% | 1.34x | ||
45.01B | 17.83% | 37.3% | 51.57% | 8.36% | 1.55x | ||
7.88B | 29.29% | 39.52% | 21.3% | 23.34% | -1.57x | ||
38.63B | 16.25% | 28.97% | 52.48% | 10.55% | 1.29x | ||
10.59B | 12.53% | 13.21% | 12.8% | 7.95% | -2.01x | ||
28.19B | 3.38% | 5.02% | 2.1% | 0.36% | 4.66x | ||
14.4B | 9.28% | 22.55% | 6.37% | 3.05% | 3.01x | ||
3.22B | 18.85% | 21.52% | 10.99% | 9.99% | -3.66x | ||
Average | 39.28B | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.22x | |
Weighted average by Cap. | 46.84B | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.54x |
- Stock Market
- Equities
- AMGN Stock
- Sector Amgen Inc.
- Financial comparisons

MarketScreener is also available in this country: United States.
Switch edition